Relmada Therapeutics, Inc. (RLMD)

4.01 -0.49 (-10.89%) USD  |  NASDAQ  |  Dec 17, 16:00
4.02 +0.01 (+0.25%) After-Hours: 20:00
More

Relmada Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade